Video

ESC 2017: EMANATE - Apixaban Versus Heparin/Vitamin K Antagonist in Anticoagulation-naive Patients with AF

Published: 25 Sep 2017

  • Views:

    Views Icon 194
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Afzal Sohaib met with Jens Cosedis Nielsen from Aarhus University Hospital, Aarhus, DK to discuss Apixaban Versus Heparin/Vitamin K Antagonist in Anticoagulation-naïve Patients with Atrial Fibrillation Scheduled for Cardioversion (EMANATE).

Filmed by Radcliffe Cardiology on-site at ESC 2017.